Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06665360Completed

Identify the State of Laminae Milling by Sound

Role: collaborator

NCT06655090Recruiting

Fibrotic Interstitial Lung Disease Early Recognition and Strategic Therapy Study in China

Role: collaborator

NCT06463756Recruiting

AI Models to Predict Thyroid Cartilage Invasion in Laryngeal Carcinoma

Role: collaborator

NCT06414655Recruiting

Multicenter Prospective Cohort Study of Twin Maternal-Child Dyads in China

Role: collaborator

All 4 trials loaded